MedPath

Theta-Burst-Stimulation in early Rehabilitation of Stroke

Not Applicable
Conditions
Stroke with hemiparesis including impaired hand motor function
I63
Cerebral infarction
Registration Number
DRKS00008963
Lead Sponsor
niversität zu Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

written consent;
age: 40-90 years;
ischemic stroke;
hemiparesis with impaired hand motor function

Exclusion Criteria

Subjects who are legally detained in an official institute (§20 MPG);
Participation in clinical trial within the last 12 weeks;
Electronic implants or ferromagnetic Implants located in the head, neck or thorax (e.g. clips, intracranial shunt, artificial heart valve, pacemaker);
Medication pump (e.g. insulin pump);
Metal splinters in eye or head;
Pregnancy / breastfeeding;
Severe Neurodegenerative disease;
Severe Neuroinflammatory disease;
History of seizures / epilepsy;
Physical addiction to alcohol, medication, or drugs (excluded: nicotine);
Insufficient compliance;
Present or past malignant tumor involving the central nervous system;
Severe Psychiatric disease;
Clinically manifest bilateral hemiparesis or infarcts in the primary motor cortex or along the tractus corticospinalis in the hemisphere ipsilateral to the hemiparesis;
Pre-existing cerebral infarctions with hemiparesis or pre-existing cerebral infarctions in the primary motor cortex or along the tractus corticospinalis, excluding microangiopathic changes (e.g. clinically asymptomatic lacunae <1cm);
Known brain lesion (surgical, traumatic);
Evidence for enhanced cerebral pressure;
Severe cardial dysfunction;
life expectancy < 12 months;
NIHSS Score > 20;
Blood glucose imbalances resistant to treatment (<50 mg/dl or >300 mg/dl);
Elevated blood pressure resistant to treatment (RR > 185/110mmHg);
Systemic Thrombolysis using r-tPA or thrombectomy within the last 24 hours before enrollment in study;
Medication with benzodiazepines, high-potency antipsychotics or tricyclic antidepressants before hospitalization or long-term during hospitalization

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
grip force after 3 months (measured with vigorimeter)
Secondary Outcome Measures
NameTimeMethod
After 8 days of intervention, and three months after stroke:<br><br>Grip force (vigorimeter);<br>Motor function (Action Research Arm Test, ARAT; Fugl-Meyer Motor Scale of the upper extremity, FM);<br>Stroke severity (National Instituts of Health Stroke Scale, NIHSS);<br>Degree of disability (modified Rankin Scale, mRS);<br>Motorcortex excitability (Motor evoked potential, MEP; Resting motor threshold, RMT);<br>Quality of life (EuroQol 5D questionnaire, EQ-5D);<br><br>Three months after stroke:<br>Activities of daily living (Barthel-Index, BI) at admission and discharge in external rehabilitation facility;<br>Days of rehabilitation after intervention phase
© Copyright 2025. All Rights Reserved by MedPath